Digoxin Use and Lower 30-Day All-Cause Readmission for Medicare Beneficiaries Hospitalized for Heart Failure

類似資料

• Beta-Blocker Use and 30-Day All-Cause Readmission in Medicare Beneficiaries with Systolic Heart Failure
  著者:: Bhatia, Vikas, 等
  出版事項: (2014)
• Association of 30-day All-cause Readmission with Long-term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure
  著者:: Arundel, Cherinne, 等
  出版事項: (2016)
• Digoxin Reduces 30-Day All-Cause Hospital Admission in Older Patients with Chronic Systolic Heart Failure
  著者:: Bourge, Robert C., 等
  出版事項: (2013)
• Renin-Angiotensin System Inhibition and Lower 30-day All-cause Readmission in Medicare Beneficiaries with Heart Failure
  著者:: Sanam, Kumar, 等
  出版事項: (2016)
• Lack of Evidence of Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure and Reduced Ejection Fraction Discharged on Spironolactone
  著者:: Lam, Phillip H., 等
  出版事項: (2016)